November 28, 2012 /PRNewswire/ --
Elsevier Infobutton now links from EHRs to key content in Clinical Pharmacology
Elsevier's Gold Standard, a leading drug information provider, announced today that its Clinical Pharmacology drug reference solution will be accessible through the recently launched
Elsevier Infobutton, a one-touch service that links from an EHR (electronic health record) to evidence-based content in Elsevier electronic information solutions. Institutions with an EHR can license and then link to Elsevier's comprehensive drug reference content in Clinical Pharmacology through clinical terms in the patient record.
The Elsevier Infobutton helps providers achieve EHR certification for Stage 2 Meaningful Use by supporting these HL7 (Health Level Seven International) Infobutton standard use cases:
- Context--sensitive links that reference information to support clinical decision-making
- Links to patient-specific education resources
is trusted by more than 2,000 hospitals nationwide and is accepted as a professional drug reference by all 50 State Boards of Pharmacy.
"The Elsevier Infobutton demonstrates real value at the point-of-care by simplifying access to clinical decision support information and patient education materials that improve care and patient outcomes," said
, President, Elsevier's Gold Standard. "Our goal continues to focus on providing solutions that elevate the standard of care through easily-accessible, user-friendly, evidence-based drug information."
The Elsevier Infobutton is offered free-of-charge to customers with an EHR who also license other Elsevier electronic information products, including Clinical Pharmacology, Mosby's Nursing Consult and Mosby's Skills.
For more information about Elsevier Infobutton please visit
About Elsevier's Gold Standard
, Elsevier's Gold Standard uses innovative technologies to provide a complete suite of drug information and decision support solutions. With a tenacious commitment to product quality, Elsevier's Gold Standard solutions empower healthcare organizations, professionals and consumers to meet the most pressing healthcare challenges, improve patient safety and ensure optimal outcomes. To learn more about Elsevier's Gold Standard, visit
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts